Phyllodes tumour of the breast: A retrospective analysis of 30 cases

Breast

Volumn 8, Issue 5, 1999, Pages 278-281

  Mokbel, K ^a   Price, R K ^a   Mostafa, A ^a   Wells, C A ^a   Carpenter, R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CYSTOSARCOMA PHYLLOIDES; DISEASE COURSE; FEMALE; FIBROADENOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 0032707230     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0058     Document Type: Article

References (19)

1. Azzopardi J G. Sarcoma of the breast. Bennington J. Problems in breast pathology. Vol. II Major problems in pathology. 1979;355-359 WB Saunders Co. Philadelphia.
2. Rowell M D, Perry R R, Hsiu J G, Barranco S C. Phyllodes tumours. Am J Surg. 165:1993;376-379.
3. Keelan P A, Myers J L, Wold L E, Katzmann J A, Gibney D J. Phyllodes tumour: clinicopathologic review of 60 patients and flow cytometric analysis in 30 patients. Hum Pathol. 23:1992;1048-1054.
4. Salvadori B, Cusumano F, Bo R D. Surgical treatment of phyllodes tumours of the breast. Cancer. 63:1989;2532-2536.
5. Reinfuss M, Mitus J, Duda K. The treatment and prognosis of patients with phyllodes tumour of the breast. Cancer. 77:1996;910-916.
6. Grimes M M. Cystosarcoma phyllodes of the breast: histological features, flow cytometric analysis, and clinical correlations. Mod Pathol. 5:1992;232-239.
7. Zurrida S, Bartoli C, Galimberti V. Which therapy for unexpected phyllodes tumour of the breast? Eur J Cancer. 28:1992;654-657.
8. Chua C L, Thomas A. Cystosarcoma phyllodes tumours. SGO. 166:1988;302-306.
9. Ciatto S, Bonardi R, Cataliotti L, Cardona G. Phyllodes tumour of the breast: a multicentre series of 59 cases. Eur J Surg Oncol. 18:1992;545-549.
10. Bartoli C, Zurridia S M, Clemente C. Phyllodes tumour in male patients with bilateral gynaecomastia induced by oestrogen therapy for prostate cancer. Eur J Surg Oncol. 17:1991;215-217.
11. Cohn-Cedermark G, Rutqvist L E, Rosendahl I, Silfverswar C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 68:1991;2017-2022.
12. Bennett I C, Khan A, De Freitas R, Chaudary M A, Millis R A. Phyllodes tumours: A clinicopathological review of 30 cases. Aust N Z J Surg. 62:1992;628-633.
13. de Roos W K, Kaye P, Dent D M. Factors leading to local recurrence or death after surgical resection of phllodes tumours of the breast. Br J Surg. 89:1999;396-399.
14. Burton G V, Hart L L, Leigh G S, Iglehart J D, McCarty K S, Cox E B. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer. 63:1989;2088-2092.
15. Hawkins R E, Schofield J B, Fisher C, Wiltshaw E, McKinna J A. The clinical and histological criteria that predict metastases from cystosarcoma phyllodes. Cancer. 69:1992;141-147.
16. Murad T M, Hines J R, Beal J, Bauer K. Histopathological and clinical correlations of cystosarcoma phyllodes. Arch Pathol Lab Med. 112:1988;752-756.
17. Palko M J, Wang S E, Shakney S E, Cottington E M, Levitt S B, Hartsock R J. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes. Arch Pathol Lab Med. 114:1990;949-952.
18. Layfield L J, Hart J, Neuwirth H, Bohman R, Trumbull W E, Giuliano A E. Relation between DNA ploidy and the clinical behavior of phyllodes tumours. Cancer. 64:1989;1486-1489.
19. Mokbel K M, Ghilchik M, Parris C N. Telomerase activity in phyllodes tumours. Eur J Surg Oncol. 25:1999;269-272.